StonvexLoading…
StonvexStonvexStonvexCore line items from HSCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $4.32K | $4.32K | $1.90K | $4.35K |
Operating Income | $-5.88M | $-3.95M | $-1.87M | $-8.35M |
Net Income | $-6.39M | $-4.41M | $-2.05M | $-8.77M |
EPS (Diluted) | $-2.61 | $-2.10 | $-1.58 | $-9.34 |
Total Assets | $7.55M | $6.00M | $6.44M | $4.22M |
Total Liabilities | $4.90M | $1.81M | $3.30M | $4.02M |
Cash & Equivalents | $3.40M | $1.95M | $2.79M | $1.10M |
Free Cash Flow OCF − CapEx | $-5.75M | $-4.30M | Not available | $-7.42M |
Shares Outstanding | 3.18M | 3.07M | 2.28M | 1.12M |